Fig. 5From: Risk factors of PSA progression and overall survival in patients with localized and locally advanced prostate cancer treated with primary androgen deprivation therapyKaplan-Meier plots showing the incidence of PSA progression-free survival rate classified by J-CAPRA risk groupingBack to article page